VACCINE SLOWS MELANOMA

Article

Antigenics Inc. has announced its experimental cancer vaccine Oncophage improved post-surgery results for patients with metastatic melanoma, with one of 18 patients remaining disease-free for almost 15 months.

Related Videos
Related Content

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Incyte to Present Numerous Studies at EADV 2023

September 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline

September 29th 2023

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

September 29th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Incyte to Present Numerous Studies at EADV 2023

September 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline

September 29th 2023

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

September 29th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Incyte to Present Numerous Studies at EADV 2023

September 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline

September 29th 2023

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

September 29th 2023
© 2023 MJH Life Sciences

All rights reserved.